Management Team
Directors
President & CEOKiichi Adachi, Ph.D.
- Department
- Corporate Strategy Office
Internal Auditor
Regulatory Affairs - Biography
-
- April 1995
- Postdoctoral Fellow of the Japan Society for the Promotion of Science
Graduate School of Agricultural and Life Sciences, The University of Tokyo - May 1996
- Postdoctoral Research Associate, Purdue University, IN, U.S.A
- March 1999
- Research Scientist,
Paradigm Genetics, Inc., NC, U.S.A - September 2002
- Joined Mitsui & Co. Global Strategic Studies Institute Senior Researcher, Biotechnology Center
- April 2004
- General Manager, Research & Development Department, the Company
- December 2004
- Director and General Manager, Research & Development Department
- December 2005
- Director and Executive Vice President
- December 2010
- Director and General Manager, Business Development Department
- April 2011
- Invited Associate Professor, Osaka University
- December 2016
- President & CEO, the Company (to present)
DirectorKoichi Murakami
- Department
- Corporate Planning Management
- Biography
-
- April 1983
- Joined Japan Recruit Center, Inc. (currently Recruit Co., Ltd.)
- October 1992
- Director, FLEX, Inc.
- November 2000
- Joined Advance Create Co., Ltd.
- February 2002
- Director and Office Manager of Corporate Planning Office
- October 2007
- Managing Executive Officer and General Manager, Corporate Administration Division
- October 2011
- Director, Managing Executive Officer, and General Manager, IT Division
- December 2014
- Director, Senior Executive Officer, and Officer Manager, Internal Audit Office
- October 2015
- Director, Managing Executive Officer, and General Manager, Compliance Division
- October 2015
- Director, Advance Create Reinsurance Incorporated
- December 2017
- Senior Managing Director and General Manager, Administration Division, Advance Create Co., Ltd.
- December 2019
- Joined Etvos Co., Ltd. Executive Officer and General Manager, Administration Department
- August 2020
- Joined NHS Insurance Group Inc. Executive Officer and CFO
- December 2021
- Director and General Manager, Corporate Planning Management Department, the Company (to present)
DirectorDaichika Hayata
- Department
- Pharmaceutical Development Department, Regulatory Affairs Department
- Biography
-
- May 2004
- Joined the Company Researcher, Research & Development Department
- December 2016
- Manager, Pharmaceutical Development Department
- January 2018
- Senior Manager, Pharmaceutical Development Department
- June 2021
- General Manager, Pharmaceutical Development Department
- December 2022
- Director and General Manager, Pharmaceutical Development Department, the Company
- August 2023
- Director and General Manager, Pharmaceutical Development, Regulatory Affairs (to present)
DirectorYoshiyuki Kayano
- Department
- Quality Assurance
- Biography
-
- April 2004
- Joined WAKENYAKU CO.,LTD.
- October 2005
- Researcher, Research & Development Department
- January 2011
- Joined OKAYAMA TAIHO Pharmaceutical Co., Ltd.
- April 2019
- Manager, Pharmaceutical Development Department
- June 2021
- Senior Manager, Pharmaceutical Development Department
- January 2023
- General Manager, Quality Assurance Department
- December 2023
- Director and General Manager, Quality Assurance Department (to present)
Part-time Directors
DirectorAkihiro Tomoyasu, Ph.D.
- Biography
-
- April 1995
- Joined Snow Brand Milk Products Co., Ltd. (currently MEGMILK SNOW BRAND Co., Ltd.)
- March 2001
- Joined Chugai Pharmaceutical Co., Ltd.
- April 2005
- Joined UFJ Capital Co., Ltd. (currently Mitsubishi UFJ Capital Co., Ltd.)
- September 2015
- Appointed as a Fellow of Anicom Capital, Inc.
- September 2015
- Representative Director and President, Tomoyasu Research Institute Co., Ltd. (to present)
- January 2016
- Director, KinoPharma, Inc. (to present)
- September 2016
- Director, Anicom Capital, Inc.
- December 2016
- Director, the Company (to present)
- April 2017
- Part-time lecturer, Genome Basic Medicine, Saitama Medical University (to present)
- July 2018
- Outside Director, GenAhead Bio Inc. (to present)
- December 2020
- Outside Director, PharmaBio Corporation (to present)
- March 2022
- Outside Director, Bio Matrix Research, Inc. (to present)
Outside DirectorKohichiro Yoshino, Ph.D.
- Biography
-
- April 1974
- Joined Kanebo, Ltd.
- April 1999
- Joined Nippon Organon K.K. Chief, Pharmaceutical Research Laboratory
- April 2003
- President and Chief Executive Officer, Representative Director, Carna Biosciences, Inc. (to present)
- April 2004
- Visiting Professor, Center for Advanced Science Innovation, Osaka University
- March 2011
- President & CEO, CarnaBio USA, Inc.
- October 2013
- Representative Director and President, ProbeX, Inc.(currently Carna Biosciences, Inc.)
- December 2018
- Outside Director, MEDINET Co., Ltd. (to present)
- December 2018
- Outside Director, the Company (to present)
Outside DirectorMasato Fukui, Ph.D.
- Biography
-
- March 2004
- Completed Doctoral program, Graduate School of Pharmaceutical Sciences, Kyoto University
- April 2004
- Postdoctoral Research Associate, Duke University Medical Center, NC, U.S.A
- April 2007
- Joined Central Research Laboratory, Nippon Zenyaku Kogyo Co., Ltd.
- April 2009
- Chief, Central Research Laboratory
- December 2012
- Research Associate, Fellowship Program, University of California, Davis, Veterinary Medical Center, San Diego / University of California, San Diego, School of Medicine, CA, U.S.A
- May 2015
- Director, Zenoaq Resource Co.,Ltd. (currently ZENOGEN PHARMA CO., LTD.)
- May 2018
- Senior Managing Director
- May 2018
- Director, Nippon Zenyaku Kogyo Co., Ltd. (to present)
- December 2020
- Outside Director, the Company (to present)
- July 2021
- Representative Director and President, ZENOGEN PHARMA CO., LTD. (to present)
Auditors
Outside AuditorNaomi Doi
- Biography
-
- March 1990
- Doctor of Science, graduate school of Science, kyushu university
- April 1990
- Joined Kaken Pharmaceutical Co., Ltd. (Pharmaceutical Research Department, Central Research Laboratory)
- February 1996
- Ph.D. of the Faculty of Medicine, Edinburgh University in the U.K. (employed by Kaken Pharmaceutical)
- February 1998
- Pharmaceutical Research Department, Research Institute, Kaken Pharmaceutical Co., Ltd.
- April 2010
- General Manager, Research & Development Administration Center of said company
- April 2012
- General Manager of Product Vigilance & Quality Assurance Dept. of said company
- June 2018
- Full-time Audit & Supervisory Board Member of said company
- June 2023
- Company Management Advisor (part-time) (to present)
- December 2023
- Outside Audit & Supervisory Board Member, CERAXIA CO., LTD. (part-time) (to present)
- December 2024
- Our External Audit & Supervisory Board Member (to present)
Outside AuditorMasahiro Motokawa, C.P.A.
- Biography
-
- November 2003
- Joined Belling Point Co., Ltd.
- June 2006
- Joined KPMG AZSA & Co., Ltd. (currently KPMG AZSA LLC)
- August 2018
- Chief, D&A Accounting Firm (to present)
- August 2018
- Representative Partner, Shingetsu Audit Firm (to present)
- December 2018
- Outside Auditor, the Company (to present)
- December 2021
- Outside Auditor, DoctorsMobile Corporation (to present)
- November 2023
- Outside Audit & Supervisory Board Member, Rivascula Bio Co., Ltd. (to present)
Outside AuditorYosuke Yamaguchi,
Attorney at law
- Biography
-
- September 2007
- Joined Kitahama Partners Foreign Law Joint Enterprise
- July 2011
- Seconded to Osaka Securities Exchange Co., Ltd. (currently Tokyo Stock Exchange Regulation)
- August 2016
- Joint partner of Iwatani Muramoto & Yamaguchi (to present)
- December 2018
- Outside Auditor, the Company (to present)
- April 2020
- Outside Auditor, akippa Inc. (to present)
- December 2021
- Outside Auditor, Fitcrew inc. (to present)
- July 2022
- Outside Auditor, Center Mobile Co., Ltd. (to present)